⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GH News
Guardant Health, Inc. Common Stock
Guidehouse Again Named Leader in Financial Crime and Compliance Operations Services by Everest Group
prnewswire.com
GH
Pear VC Raises $333M Fund V to Double Down on Finding Founders Before the Market Does
businesswire.com
DASH
GH
Guardant Health to Report Third Quarter 2026 Financial Results on November 5, 2026
businesswire.com
GH
Breast Cancer Continues to Impact Communities; New York Rallies Together to Take Action at Susan G. Komen® MORE THAN PINK Walk
businesswire.com
PFE
LLY
NTRA
DGX
GH
NVS
Liquid Biopsy with Emphasis on Cancer Market to Reach $8.0 Billion by 2031, Driven by Rising Cancer Incidence and Precision Medicine Adoption
globenewswire.com
GH
NTRA
EXAS
ILMN
TMO
QGEN
MYGN
PSNL
FRNM
Precision Oncology Advances Reshape the Lung Cancer Liquid Biopsy Market as Early Detection Gains Momentum
globenewswire.com
GH
TMO
NTRA
ILMN
BIO
BRBR
EXAS
LH
NEO
PSNL
QGEN
MDXH
Andela Research Finds That 53% of AI Job Postings Seek Skills That Don't Match Job Title; Also Identifies New Emerging Tech Roles
prnewswire.com
MA
GH
Guardant Health and Collaborators to Present 20 Abstracts Highlighting Portfolio of Liquid Biopsy Tests for Early Detection and Ongoing Treatment Management at 2026 World Conference on Lung Cancer
businesswire.com
GH
Blood Based Biomarkers Market Report Now Available — See Why the First FDA-Cleared Alzheimer's Blood Test Just Redrew the Competitive Map
globenewswire.com
ABT
TMO
DGX
LH
BIO
QTRX
GH
Guardant Health Announces Landmark FDA Approval of Guardant360 ® CDx as Companion Diagnostic for AstraZeneca’s ETCAMAH ™ (camizestrant) in Advanced Breast Cancer
businesswire.com
GH